rilzabrutinib 400 MG Oral Tablet

RxCUI: 2722403
RxNorm name: rilzabrutinib 400 MG Oral Tablet
Display name: rilzabrutinib 400 MG Oral Tablet
Full name: rilzabrutinib 400 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
WAYRILZ	RILZABRUTINIB	Genzyme Corporation	95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0	2025-08-26	Warnings, Adverse reactions	Exact identifier rxcui: 2722403

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0	rilzabrutinib 400 MG Oral Tablet [PSN] · rilzabrutinib 400 MG Oral Tablet [SCD]	2	6	These highlights do not include all the information needed to use WAYRILZ™ safely and effectively. See full prescribing information for WAYRILZ. WAYRILZ™ (rilzabrutinib) tablets, for oral use Initial U.S. Approval: 2025	20250826